Isotope Production at LERF

Similar documents
Cyclotron & Medical Isotopes Best Theratronics announces plans to address the medical isotope shortage by manufacturing a range of cyclotrons

LUTETIUM 177 BROAD PRODUCTION CAPABILITIES ARE EXPECTED TO STIMULATE CLINICAL APPLICATIONS OF THIS IMPORTANT THERAPEUTIC RADIOISOTOPE

KIPT ADS Facility. Yousry Gohar 1, Igor Bolshinsky 2, Ivan Karnaukhov 3. Argonne National Laboratory, USA 2. Idaho National Laboratory, USA 3

medicine represents more than 20 Billion $ in medical fees 99m Tc are conducted in the world. This not only is

KIPT ACCELERATOR DRIVEN SYSTEM DESIGN AND PERFORMANCE

Accelerator targets design - The challenge of high power density. Ido Silverman DAPNIA visit 24/10/07

NUCLEAR MEDICINE SUMMARY AND TABLE OF CONTENTS WORLD MARKET REPORT & DIRECTORY EDITION 2017

Report from Turku. Scanditronix Cyclotron Workshop Uppsala 23-25th May Stefan Johansson

Medical Isotope Production by Electron Accelerators. R.S. Orr University of Toronto

Radiation Environment and Shielding Design Optimization at MEIC

A main application of tungsten alloy products, tungsten alloy radiation containers are widely applied in medical and nuclear industries.

Radiation Backgrounds for the APEX experiment

LOS ALAMOS AQUEOUS TARGET/BLANKET SYSTEM DESIGN FOR THE ACCELERATOR TRANSMUTATION OF WASTE CONCEPT

NIIEFA Accelerators for Industry and Medicine

Radiopharmacies, Radioisotopes and Accelerators Team BEST developments

Concept for tests of a gallium-

Regulatory aspects: Radiopharmacy (GMP)

BLIP 2017 Summary and 2018 Plans

CYCLONE 70 CHOOSE WITH CONFIDENCE

NuMI/LBNF Radiation Protection. Jim Hylen NBI September 2017

New Treatment Facility and Targeted Alpha-particle Therapy in FMU

Ge / 68 Ga GENERATOR* HOW TO DO PET AS SIMPLY AS SPECT? EXCELLENCE DEDICATED TO NUCLEAR MEDICINE, HEALTHCARE & ENVIRONMENT

LERF Experimental Review Process

Radioisotopes production technology -EGYPT experience

IMPROVEMENTS OF HIGH CURRENT/ LOW PRESSURE LIQUID AND GAS TARGETS FOR CYCLOTRON PRODUCED RADIOISOTOPES

Production of 177 Lu n.c.a. in high-flux reactors

World status on reactor and cyclotron radioisotope production

UWMCF Quick Facts. History. UWMCF Technical Support Group. Accelerator: Original equipment cost: Original building cost:

A Bridge not too Far: Personalized Medicine with the use of Theragnostic Radiopharmaceuticals

2 / 1. SUMMARY public, should be well documented, and should be reviewed on a regular basis to determine whether it continues to meet the operational

IAEA assistance in RI production and supply: 99 Mo case

PRODUCTION AND DEVELOPMENT OF RADIOISOTOPES IN HANARO

Brachytherapy Practice Problems EXTRA

NOTIFICATION ON SCHEDULE OF PRESCRIBED SUBSTANCES UNDER ATOMIC ENERGY ACT January 2006

Status of Mo-99 Supply and New Developments

BINP accelerator based neutron source S. Taskaev

RADIUM DISPOSITION OPTIONS FOR THE DEPARTMENT OF ENERGY

Measuring Ytterbium Neutron Cross Section at 2.5 MeV. Norbert Hugger

Staged Introduction of Non-power and Power Nuclear Technologies to Newcomer Countries. Mitsuru Uesaka

production using Lighthouse accelerator J.W. Blokker

Measurement of Deuteron-Induced Activation Cross-Sections for. Aluminum, Copper and Tungsten in MeV Region

The Current State of Mo-99 Supply and the Conversion to LEU

Development of a Dose Profiler for range monitoring in particle therapy

Soil, Groundwater and Cooling Water

Activation cross-sections of proton induced reactions on nat Hf in the MeV energy range: production of 172 Lu and of 169 Yb

MARSHIELD NUCLEAR. When safety & success must be Absolutely Assured.

JORDAN RESEARCH AND TRAINING REACTOR UTILIZATION FACILITIES

Radiation at accelerator laboratories

Which radionuclide for solid tumour treatment

Table S-2. Roadmapping Neutron Sources. Table S-2. Roadmapping Neutron Sources (continued)

Factors Affecting QE and Dark Current in Alkali Cathodes. John Smedley Brookhaven National Laboratory

For further details of how CITs Digital Radiography Solutions can help YOUR organisation, please contact us at the address below

DOE/NNSA Off-Site Source Recovery Program

THE DETERMINATION OF CARBON-14 IN ACTIVATED METAL WASTES

CONTAMINATED SCRAP METAL-DIFICULTIES TO DETECT. Paulo Fernando Lavalle Heilbron Filho Nerbe J. Ruperti Junior. Abstract

Legislative Framework for the Regulation of Decommissioning at Egypt. Prof. Dr. Farouk M. A. Rahman

Transmutation of Transuranic Elements and Long Lived Fission Products in Fusion Devices Y. Gohar

Appendix-2 Country Report on Isotope Production and Its Applications

1 hour 24 hours. Two images from the successful in-vivo test of gamma camera imaging of Radspherin distribution in the peritoneal cavity of rats

Free Electron Laser Nitriding of Metals: From. basis physics to industrial applications

EXPERIENCES OF HEU TO LEU MO-99 PRODUCTION CONVERSION

Neutronics Simulations of 237 Np Targets to Support Safety-Basis and 238 Pu Production Assessment Efforts at the High Flux Isotope Reactor

in94070.txt at Page 1 of 5 2/24/00

Accelerator Driven Systems for Thorium Utilisation in India

MEDICAL PHYSICS (MED PHYS)

Chapter 3 Obtaining an Authorization to Possess and Use Radioactive Material

MEEM 4200 Energy Conversions Michigan Tech University April 4, 2008 Jeff Katalenich

Erdong Wang Brookhaven National Laboratory

Progress with crystal testing and selection

IFMIF LITHIUM LOOP ACTIVATION AND ASSOCIATED OPERATOR DOSE RATES

Distillation: Waste Water Treatment for Release to Sewers Jung Bae Eckert & Ziegler Isotope Products, Valencia, California 91355

Session -III The growth of EB and X Ray technologies Electron Beam and X Ray equipment; State of the Art

THE ACCELERATOR PRODUCTION OF TRITIUM PROJECT

Applications of Accelerators. Prof Rob Edgecock Rutherford Appleton Laboratory and University of Huddersfield

Radionuclide production for therapeutic radiopharmaceuticals $

Improvement of construction of recombination chambers for mixed radiation dosimetry at work places

The Critical Need for Nuclear Medicine Radioisotopes and Research

Air Shipment of Radioactive Materials in Depleted Uranium Shielded Packaging

X-ray: The emerging alternative to gamma irradiation. October 13 th 2015 Regional Meeting on use of E-beam or X-Ray for Phytosanitary Applications

IAEA Technical Meeting on Products and Services of Research Reactors 28 June 2 July 2010 IAEA, Vienna, Austria

CANDU Fundamentals. Table of Contents

STUDY OF THE ELUTION OF 99 Mo- 99m Tc GENERATORS PRODUCED AT IPEN-CNEN/SP

PRINCIPLES OF OPERATION

Complies with the monograph for Parenteral Preparations and with that for Radiopharmaceuticals.

LOW-LEVEL RADIOACTIVE WASTE FORUM, INC.

Radiation Technology for Industries, the Role of IAEA

Planning for the Decommissioning of the ASTRA-Reactor

On the neutron transparency of various materials proposed for the AIDA enclosure

THALLOUS ( 201 Tl) CHLORIDE INJECTION: Revised Final text for addition to The International Pharmacopoeia (January September 2009)

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

EXPERIMENTAL STUDIES OF TARGETS AND COLLIMATORS FOR HIGH INTENSITY BEAMS*

San Onofre Unit 1 Decommissioning

THE IEA-R1 RESEARCH REACTOR: 50 YEARS OF OPERATING EXPERIENCE AND UTILIZATION FOR RESEARCH, TEACHING AND RADIOISOTOPES PRODUCTION

BRACHYTHERAPY SEED DESIGN

INSTITUTE FOR RADIOELEMENTS YOUR SUCCESS IS OUR PASSION EXCELLENCE DEDICATED TO NUCLEAR MEDICINE, HEALTHCARE & ENVIRONMENT

INNOVATIVE RADIOPHARMACEUTICALS : A realistic application of personalized medicine by Atlantic Biotherapies " Eurobio, Lille, September 25th

UTILIZATION OF ETRR-2 AND COLLABORATION 1. INTRODUCTION

NUCLEAR APPLICATION IN THE REPUBLIC OF KAZAKHSTAN. Kurchatov 2013

Measurement of Radio-nuclides in Radioactive aerosols produced in a 120-GeV Proton Target Station


Transcription:

Isotope Production at LERF Andrew Hutton Jefferson Lab for Hari Areti, Pavel Degtiarenko, Joe Gubeli, Kevin Jordan, George Kharashvili, George Neil Jefferson Lab Sundaresan Gobalakrishnan, Jamal Zweit Virginia Commonwealth University Doug Wells New Mexico Tech August 1, 2017

JLAB Low Energy Recirculator Facility (LERF) LERF is an Energy Recovery Linac World s first high power FEL Still holds power records for FEL and ERL operation 2 Beam accelerated from 9 to 170 MeV and then decelerated back to ~10 MeV, to recover the energy 2

LERF Capabilities The ERL in the LERF is available for: Fixed target experiments at medium current Internal target experiments at high current Offline accelerator research and development Diagnostic development FEL studies in the IR and UV THz production Parameter Current (ERL) Energy Charge Frequency Current (fixed target) Maximum value 8 ma 170 MeV 150 pc 75 (750) MHz 0.5 ma 3

Jefferson Lab for Isotope Production Low Energy Recirculator Facility (LERF) is proposed for isotope production in non-erl mode Up to 150 MeV energy electron beam Up to 100 kw beam power 4

Schematic of ERL-Based Isotope Production LERF can also produce isotopes in ERL mode Presentation by Rol Johnson in Radio-Isotope-1 Session on Tuesday

NSAC Isotopes Recommendations on Isotope R&D Continue support for R&D on the production of alpha-emitting radioisotopes Support R&D into the production of high specific activity theranostic radioisotopes Continue support for R&D on the use of electron accelerators for isotope production This study addresses all of these Support R&D on the development of irradiation materials for targets that will be exposed to extreme environments to take full advantage of the current suite of accelerator and reactor irradiation facilities 6

Isotope Production Collaboration Jefferson Lab: Hari Areti, Pavel Degtiarenko, George Kharashvili, Joe Gubeli, Kevin Jordan, George Neil Radiation physics, health physics, Monte-Carlo modeling, radiation metrology, high-power SRF electron accelerators, targetry, beam diagnostics, beam dumps Virginia Commonwealth University: Jamal Zweit, Sundaresan Gobalakrishnan Radiochemistry, radiopharmaceuticals, medical imaging, nanotechnology New Mexico Tech: Doug Wells Photonuclear physics, activation analysis, isotope production 7

Recent Activities 2012 Proposal for isotope production using LERF in ERL configuration submitted to DOE Isotope Program not funded (DE-FOA-000743) 2015 Pre-R&D Proposal Funded by DOE Isotope Program 2015 White paper for photoproduction of 67 Cu 2016 R&D proposal for 67 Cu production DOE Isotope Program not funded in 2017, under consideration for 2018 funding (DE-FOA-0001588) 2017 US patent application: 67 Cu Photoproduction in Gallium 2015/2017 Proof of concept studies 67 Cu production in gallium and zinc targets at CEBAF injector 67 Cu separation from gallium at VCU 8

67 Cu for Targeted Radiotherapy Theranostic radionuclide 141 kev mean energy β - for therapy (range in tissue is about a cell diameter) 185 kev energy γ for SPECT imaging Can be paired with 64 Cu for PET imaging Near-ideal half-life of 61.8 hours Convenient for production, transportation, and delivery to patient Same order as biological half-life of copper and zinc ( 67 Cu decays to stable 67 Zn) Favorable biochemistry approved for human trials Copper and zinc are essential for structural and functional activities of many proteins, enzymes and transcription factors Not acutely toxic both copper and zinc are essential trace nutrients 9

Demand and Availability of 67 Cu Historical lack of an adequate and reliable supply has impeded the development of 67 Cu applications Estimate of potential long-term US demand based on treating half of all new Non-Hodgkin Lymphomas gives ~12,000 Ci / year Smith, Bowers, Ehst, The production, separation, and use of 67 Cu for radioimmunotherapy: A review, Applied Radiation and Isotopes 70 (2012) 2377 2383 67 Cu is currently produced at: Brookhaven National Laboratory: Proton irradiation of zinc, produced periodically, ~60% of activity upon delivery is composed of 64 Cu Argonne National Lab LEAF: Photoproduction reaction producing 100 mci batches on demand, expandable to 2 Ci batches Idaho Accelerator Center: Photoproduction in zinc up to 10s of mci / week, not intended for human use Higher specific activities and improved radiological purity are desired 10

Photoproduction of 67 Cu in Gallium via 71 Ga(γ,α) 67 Cu (1) Gallium has favorable properties for high power targets Low melting point of 30 C High boiling point of 2204 C Low vapor pressure Corrosive to metals except tungsten and tantalum 50 kw irradiation of a Gallium target once per week will produce* 100s mci of 67 Cu per week in natural gallium > 1 Ci/week in 71 Ga (40% of natural Gallium) Typical medical dose of 67 Cu order of 10 mci * Yields are calculated using FLUKA and scaled with data 11

Photoproduction of 67 Cu in Gallium via 71 Ga(γ,α) 67 Cu (2) Modest cross-section of 71 Ga(γ,α) 67 Cu reaction can be compensated by high beam power and a thick target Koning et al. "TENDL-2015: TALYS-based evaluated nuclear data library https://tendl.web.psi.ch/te ndl_2015/tendl2015.html 12

Photoproduction of 67 Cu in Gallium via 71 Ga(γ,α) 67 Cu (3) High-Z Radiator Bremsstrahlung photons Isotope production 50 kw Electron beam Beam Pipe Coolant flow Cooling Jacket Target container Liquid gallium Coolant lines 13

Overall Objectives and First Steps The overall objective is to integrate Production Chemical Separation Delivery First (opportunistic) steps Confirm 67 Cu production in gallium Chemically separate 67 Cu from gallium Investigate 67 Cu delivery mechanisms 14

First Opportunistic Irradiation Test Irradiation of Gallium and Zinc targets during beam studies in CEBAF injector: 18.5 MeV (to avoid interference from 67 Ga), 2.5 µa, 1 h ~ 0.1 µci 67 Cu detected in each target Natural Gallium target Boron Nitride crucible Beryllium window 1mm Tungsten radiator Kapton tape to prevent Gallium spills Natural Zinc target 15

Chemical Separation Test Chemical separation test at Virginia Commonwealth University (VCU) 1 mci of 67Cu was obtained from the National Isotope Development Center Shipped from BNL to VCU The sample was dissolved in hydrochloric acid and added to gallium chloride in solution Separation by liquid-liquid extraction and column chromatography recovered ~95% of the radioactive copper after a single pass 16

Second Opportunistic Irradiation Test (1) During 2017 beam studies of 4K operation in CEBAF injector, there was a parasitic opportunity for isotope irradiation 85 g gallium target irradiated for several hours at 18.65 MeV, 50 µa (~1 kw) with the goal of chemically separating 67 Cu Hexagonal Boron Nitride Capsule Gallium Target Tungsten radiator Beryllium Window 17

Second Opportunistic Irradiation Test (2) Due to failure of monitoring instrumentation, run was terminated earlier than anticipated ~130 µci 67 Cu was produced, ~70 µci was available at the time of sample retrieval (aimed to produce ~500 µci) Due to transportation and communication issues did not proceed with chemical separation The two, low-energy irradiation tests showed reasonable agreement with the model predictions FLUKA (our primary tool for activation calculations) appears to overestimate 67 Cu yields in Gallium by approximately a factor of 2 at 18.5 MeV maximum bremsstrahlung energy 18

Summary and Proposed Future Work 67 Cu production via the 71 Ga(γ,α) 67 Cu reaction at LERF: Production of high specific activity, theranostic isotope using a high-power electron accelerator Measured photoproduction of 67 Cu at low energies (< 20 MeV) No 64 Cu content detected Chemically separated 67 Cu from Gallium Obtained from BNL, then dissolved in Gallium Proposed future work Complete smooth integration of photoproduction and chemical separation Produce 67 Cu in Gallium target at optimal electron beam energies (> 30 MeV) Develop high power target system Investigate photoproduction of α-emitters 225 Ac production in 226 Ra, 230 Th, 232 Th targets 19